This study investigated for the first time the effects of the cis isomer of resveratrol (c-RESV) on the responses of inflammatory murine peritoneal macrophages, namely on the production of reactive oxygen species (ROS) and reactive nitrogen species ( 
INTRODUCTION
A number of large-scale epidemiological studies have suggested that a prolonged and moderate consumption of red wine by the Southern French and other Mediterranean populations, despite a high-fat diet, little exercise, and widespread smoking, is associated with a very low incidence of cardiovascular diseases, mainly coronary heart disease (the so-called French paradox) [1] .
The cardioprotective effects of red wine appear to be independent of alcohol content, and over the last few years, numerous studies have been performed with the aim of identifying the components responsible. Although these compounds have yet to be conclusively identified, the principal candidates are a number of polyphenolic compounds such as stilbenes and flavonoids (for review, see, e.g., ref. [2] ).
Resveratrol [3,4Ј,5-trihydroxystilbene (RESV)] is a natural phytoalexin (phytoestrogen) synthesized in response to injury or fungal attack, found in grape skin, and notably, in red wine in its two isomers, trans and cis (ref. [3] ; see Fig. 1 ). A wide range of RESV concentrations in the different wines analyzed (depending on a number of factors) has been reported. In some wines, the cis isomer is in higher concentrations than the trans isomer, whereas in other wines, the predominant form is the trans-resveratrol (t-RESV; see, e.g., refs. [4, 5] ). To date, the majority of studies of pharmacological effects have considered t-RESV, which has been proposed as one of the principal candidates involved in the cardioprotective effects of red wine (see, e.g., ref. [6] ). This isomer of RESV displays in the in vitro, ex vivo, and/or in vivo experiments a number of pharmacological effects including modulatory lipoprotein metabolism, antiinflammatory, platelet antiaggregatory, anticarcinogenic, and vasodilatory properties, as has been reviewed previously (see, e.g., refs. [3, 7] ). Some of these pharmacological effects seem to be implicated in the cardiovascular protection attributed to t-RESV and red wine [7] . In contrast, much less is known about the pharmacological activity of the cis isomer (c-RESV), possibly as a result of the fact that c-RESV (unlike the trans isomer) is not available commercially. A few studies have demonstrated only quantitative differences in the activity of the two forms; for example, the cis isomer induces a greater decrease in collagen-induced platelet aggregation than the trans isomer [8] , and in the cyclooxygenase (COX)-1 assay, t-RESV appears to be more active than c-RESV [9] .
During phagocytosis or stimulation with any of a wide variety of agents, macrophages activate various cell processes including the respiratory burst, in which an increase in oxygen uptake results in the production of reactive oxygen species (ROS), critical for successful defense against invading organisms [10] . ROS production occurs through two main mechanisms.
One is activation of a multicomponent nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate (NADH/NADPH) oxidase, which is assembled at the plasma membrane and cytosolic protein components and catalyzes the vectorial synthesis of superoxide radicals (O 2
•Ϫ ) from oxygen and cellular NADPH (the preferred substrate in phagocytic cells), supplied by the hexose monophosphate shunt (see, e.g., ref. [11] ). The second is stimulation of the enzyme xanthine oxidase (XO), which catalyzes the oxidative hydroxylation of purine substrates (e.g., xanthine or hypoxanthine) at the molybdenum center (the reductive half-reaction) with production of uric acid and the subsequent reduction of O 2 at the flavin center with generation of O 2
•Ϫ or H 2 O 2 (the oxidative half-reaction) [12, 13] . Increased ROS production by activated macrophages is also involved in immune diseases, and ROS excess (oxidant/antioxidant imbalance) may play an important role in the (patho)-physiology associated with the progression of various chronic inflammatory disorders, such as atherosclerosis, rheumatoid arthritis, osteoarthritis, lung diseases, and neurodegenerative diseases [14 -18] . In addition, during the respiratory burst, macrophages also produce nitric oxide (NO • ), a major radical nitrogen species (RNS), which reacts with superoxide to form peroxynitrite, a potent microbicidal agent [19] . NO
• and prostaglandin E 2 (PGE 2 ), produced by inducible NO • synthase type 2 (NOS-2) from the amino acid L-arginine and inducible COX-2, respectively, are also important mediators in inflammation processes [20] . In this context, a possible role of macrophage activation in different steps of coronary heart disease has been shown by several studies (see, e.g., refs. [21] [22] [23] ). Because of its effects on activated macrophages and on other cell types, t-RESV has been proposed in a number of previous studies as one of the components present in red wine that may confer specific protection against ischemic heart disease [7, 24] . To date, however, there have been no studies of the effects of c-RESV on macrophage respiratory burst responses or on production of inflammatory mediators. In the present study, we investigated the in vitro effects of c-RESV on ROS and RNS generation during the respiratory burst of murine thyoglicollate-elicited macrophages. Specifically, we investigated effects of c-RESV on the activities of the O 2
•Ϫ -generating enzymes NADH/NADPH oxidase and XO; whether c-RESV is able to scavenge O 2
•Ϫ
; and whether c-RESV modulates NOS-2/ COX-2 gene or protein expression and PGE 2 production in inflammatory peritoneal macrophages stimulated with lipopolysaccharide (LPS) and interferon-␥ (IFN-␥).
MATERIALS AND METHODS

Animals
The animals used throughout this study [Wistar rats (age 8 -10 weeks; IffaCredo, L'Arbresle, Lyon, France), purchased from Criffa (Barcelona, Spain), and BALB/c mouse obtained from Harlan OLAC Ltd. (Oxon, UK)] were housed, cared for, and acclimatized (before the experiments) as previously indicated [6] . 
Ethical approval
Isolation of murine peritoneal-exudate macrophages
For induction of inflammatory responses, animals were injected intraperitoneally (i.p.) with 1 ml (rats) or 0.5 ml (mouse) 3% (w/v in water) thioglycollate broth, and peritoneal exudate was extracted 5 days later. Rat and mouse inflammatory peritoneal macrophages were obtained from animals killed by cervical dislocation in a laminar flow chamber to ensure sterile conditions, as described previously by Leiro et al. [25, 26] . More than 97% of the adherent cells showed nonspecific esterase activity, determined as per Strober [27] , indicating that they were macrophages.
Assay of ROS generation
The extracellular and intracellular production of ROS during the respiratory burst response of rat thioglycollate-elicited macrophages (i.e., macrophages from rats that had received thioglycollate broth i.p. 5 days previously) was evaluated with OxyBURST Green probes (Molecular Probes, Leiden, The Netherlands) using the OxyBURST Green dihydro-2Ј,4,5,6,7,7Ј-hexafluorofluorescein/bovine serum albumin (BSA) reagent for quantification of extracellular release of ROS induced by phorbol 12-myristate 13-acetate (PMA) and the amine-reactive OxyBURST Green succinimidyl ester of 2,7-dichlorodihydrofluorescein (H 2 DCF) diacetate reagent conjugated to Kluyveromyces lactis yeast cells for quantitation of intracellular production of ROS as described previously [25, 26] .
Generation of O 2
•Ϫ by use of the enzymatic hypoxanthine oxidase (HX)-XO system
The O 2 •Ϫ was generated enzymatically in an HX-XO system and quantified by spectrophotometric measurement of the product of the reduction of nitroblue tetrazolium (NBT; Sigma, Alcobendas, Spain), essentially following the procedure described previously [6, 26] .
Determination of NADH/NADPH oxidase activity
Rat peritoneal macrophages that had been prestimulated in vivo with thioglycollate were obtained and counted as described previously [25, 26] , washed once by centrifugation at 1000 g for 10 min at 4°C, and resuspended in 1 ml Hanks' balanced salt solution (HBSS) to an approximate concentration of 30 -40 ϫ 10 6 cells/ml. These cells, maintained on ice, were immediately lysed by sonication at 60 W for 1 min (two pulses of 30 s) to give the macrophage extract. Lysis was confirmed by light microscopy. O 2 •Ϫ production was measured in this extract by lucigenin-enhanced chemiluminescence (ECL) as described by Orallo et al. [6] and Leiro et al. [26] , using 100 M NADPH (tetrasodium salt, Sigma; freshly diluted in HBSS) as substrate for NADH/NADPH oxidase.
Determination of XO activity by use of the xanthine-XO system
The potential effects of c-RESV on XO activity were tested by measuring its effects on uric acid formation from xanthine following the general method indicated in Orallo et al. [6] .
Determination of XO activity by lucigenin-ECL assay
This assay was the same as the NADH/NADPH oxidase assay (see above) except that the NADH/NADPH oxidase substrate NADPH was replaced with the XO substrate xanthine (100 M). The chemiluminescence signal emitted in these assays was approximately half that emitted with NADPH as substrate.
Assay of nitrite production NO • production was estimated on the basis of nitrite production in rat macrophage culture supernatants, measured by the Griess reaction, as described elsewhere [25, 28] .
Determination of PGE 2 in culture supernatants
Aliquots (100 l) of the rat macrophage suspension (10 6 peritoneal macrophages per ml, obtained after prestimulation with thioglycollate as indicated above) were incubated for 3 h with LPS [100 ng/ml in Dulbecco's modified Eagle medium (DMEM); Sigma] plus IFN-␥ (10 units/ml in DMEM); c-RESV at various concentrations (1, 10, or 100 M in DMEM) or indomethacin (a known, nonselective inhibitor of COX expression and COX enzymatic activity; ref. [29] ) at 30 M; or without c-RESV or indomethacin (controls) in 96-well microculture plates at 37°C under 5% CO 2 in a humidified incubator. The plates were centrifuged at 400 g for 5 min, and PGE 2 levels were determined in the supernatant by using a competitive binding immunoassay (R & D Systems, Minneapolis, MN) following the manufacturer's instructions.
Determination of NOS-2 and COX-2 mRNA levels by reverse transcriptase-polymerase chain reaction (RT-PCR)
Aliquots (1 ml) of 10 7 inflammatory rat peritoneal macrophages prestimulated in vivo 5 days previously with thioglycollate were incubated for 2 h at 37°C in DMEM containing 10 units/ml IFN-␥, 100 ng/ml LPS, and c-RESV (1, 10, or 100 M) or without c-RESV (controls). Total RNA was isolated from macrophage samples using a monophasic solution of phenol and guanidine thiocyanate (Tripure isolation reagent, Roche, Basel, Switzerland) following the manufacturer's instructions. The resulting RNA was dried and then dissolved in diethylpyrocarbonate-treated RNase-free water at 1 g/ml (Sigma). cDNA synthesis was accomplished as described previously [26] . The resulting cDNA (100 ng) was amplified by the PCR using a specific murine NOS-2 forward/ reverse primer pair, 5Ј-TGGAAGCCGTAACAAAGGAAA-3Ј/5Ј-ACCACTCG-TACTTGGGATGCT-3Ј [selected from the complete sequence of NOS-2 mRNA; GenBank of the National Center for Biotechnology Information (NCBI), accession number U03699], and a specific COX-2 forward/reverse primer pair, 5Ј-TGATCGAAGACTACGTGCAAC-3Ј/5Ј-TCATCTCTCTGCTCTGGTCAA-3Ј (NCBI, accession number NM_011198). Amplification of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) with the forward/reverse primer pair, 5Ј-ACCGCATCTTCTTGTGCAGT-3Ј/5Ј-GCCAAAGTTGTCATGGATGA-3Ј (NCBI, accession number AF106860), was performed as a control of gene expression. Thermal cycling conditions were as follows: initial denaturing at 94°C for 5 min; then, 35 cycles at 94°C for 30 s, 55°C (NOS-2 and COX-2) or 53°C (GAPDH) for 45 s, and 72°C for 1 min; and finally, a 7-min extension phase at 72°C. In all experiments, we performed RT-PCR controls without RNA or without RT; in no case were amplification products obtained. PCR products (20 l aliquots) were separated on a 2% (w/v) agarose gel in Tris-boric acid-EDTA buffer, stained with 0.5 g/ml ethidium bromide, and photographed with a digital camera under Spectroline 312 variable-intensity UV transilluminator (Spectroline, New York, NY). Bands were quantified in tagged image file format (TIFF) using densitometry analysis software (ImageMaster Total Laboratory, ver. 2.00, Amersham Biosciences Europe GmbH, Barcelona, Spain).
Slot-blot assay
The levels of the enzymes COX-2 and NOS-2 were determined by slot-blot assay in soluble extracts. Cultures of inflammatory mouse peritoneal macrophages (10 7 cells/ml) stimulated in vitro for 6 h in DMEM containing 10 units/ml IFN-␥, 100 ng/ml LPS, and c-RESV at various concentrations (1, 10, and 100 M) or without drug (controls) were incubated at 37°C in a humidified 5% CO 2 atmosphere. After this incubation period, cells were washed with Tris-buffered saline (TBS: 50 mM Tris, 0.15 M NaCl, pH 7.4) and resuspended in 0.4 ml TBS and 0.1 ml protease inhibitor cocktail (Sigma) containing 104 mM 4-(2-amino-ethyl)-benzenesulfonyl fluoride, 80 M aprotinin, 2 mM leupeptin, 4 mM bestatin, 1.5 mM pepstatin A, and 1.4 mM E-64 [N-(transepoxysuccinyl)-L-leucine-4-guanidinobutylamine]. Thereafter, the mouse peritoneal macrophages (maintained in ice) were sonicated at 60 W for 15 s and centrifuged for 5 min at 13,000 g, and the protein concentration in the supernatant was measured by the Bradford method [30] using BSA as standard. Equal amounts of total protein (60 g in 100 l) were transferred to a hydrophobic polyvinylidene difluoride membrane (Hybond-P, Amersham Biosciences) using a slot-blot filtration manifold (Amersham Biosciences). Membranes were subsequently blocked with 5% (w/v) nonfat milk powder in TBS containing 0.2% (w/v) Tween 20 for 1 h, and COX-2 and NOS-2 were immunodetected by incubation for 1 h at room temperature with a rabbit polyclonal antiserum against murine COX-2 (Cayman Chemical Co., Ann Arbor, MI) and NOS-2 (Alpha Diagnostic International, San Antonio, TX) diluted 1:1000 in dilution buffer [TBS containing 0.05% (w/v) Tween 20 and 1% (w/v) nonfat dry milk]. After incubation with primary antibody, the membranes were washed five times with washing buffer [TBS containing 0.05% (v/v) Tween 20], incubated for 1 h at room temperature with the secondary antibody (horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin, Amersham Biosciences) at 1:3000 in dilution buffer, and washed five times with washing buffer. Finally, antibody binding was visualized by ECL detection (Amersham Biosciences) following the instructions from the supplier, using autoradiography film (Hyperfilm ECL, Amersham Biosciences). Bands in films were then scanned, stored as TIFF images, and analyzed by means of a densitometry analysis software (ImageMaster Total Laboratory, ver. 2.00, Amersham Biosciences). To convert relative light units (RLU; pixel intensity) into ng/mg protein, ovine COX-2 (Cayman Chemical Co.) and mouse NOS-2 peptide (a 19-amino acid peptide sequence designated INOS22-P; control peptide; 1125-1144 amino acids, Alpha Diagnostic International) were used as standards.
Stimuli, drugs, and chemicals
K. lactis (strain NRRL-41140) yeast cells were cultured on yeast extractpeptone-dextrose medium (Sigma) at 30°C at a growth rate of 0.07/h, then washed with distilled water, and finally freeze-dried. Stock solution of LPS from Escherichia coli serotype 0111:B4 (Sigma) was made up at 10 mg/ml in phenol-red-free DMEM (Sigma) containing 0.584 g/l glutamine (Sigma) and stored at -20°C until use. Thioglycollate broth (Merck, Darmstadt, Germany) was prepared to a concentration of 3% (w/v) in phosphate-buffered saline (PBS), autoclaved at 121°C for 10 min, and stored at room temperature until use. Recombinant murine IFN-␥ was purchased from Genzyme (Cambridge, MA). Stock solution (100 mM) of PMA (Sigma) was dissolved in dimethyl sulfoxide (DMSO) and stored in the dark at -80°C until use.
For preparation of c-RESV (Fig. 1) , a solution of 500 mg t-RESV (Sigma) in 300 ml methanol was irradiated (ϭ254 nm) for 8 h. The solvent was then evaporated under reduced pressure, and the residue was purified by highpressure liquid chromatography in a reverse-phase column (Cyclobond I2000 RSP, Astec, Whippany, NJ) using 1:1 methanol-water as eluent to give an oil, c-RESV (390 mg), and a white solid, t-RESV (100 mg). Retention times (flux of 1 ml/min in column of 500ϫ9. HX, sodium azide, xanthine, superoxide dismutase (SOD; from bovine erythrocytes), diphenyleneiodonium chloride (DPI), allopurinol, XO (from buttermilk), sulfanilamide, and naphthylenediamine hydrochloride were all purchased from Sigma. Appropriate dilutions of the above drugs were prepared every day immediately before use in PBS (XO assays), in HBSS (NADPH oxidase assays), and/or in deionized water (for the other experiments) from the following concentrated stock solutions kept at Ϫ20°C: SOD (20 kunits/ml) in deionized water, HX and xanthine (10 mM) in a 0.1% w/v aqueous KOH solution; all other compounds (100 mM) in deionized water. Xanthine oxidase was dissolved daily before the experiments in PBS. Deionized water and the appropriate dilutions of the different vehicles used had no significant, pharmacological effects in any of the tests performed in the present study. In addition, unlike t-RESV, c-RESV is a stable compound and never isomerized to the trans isomer during storage or throughout the period in which the different experiments were performed.
The specific chemicals and materials used in the different tests were purchased from suppliers indicated in the corresponding references provided in Materials and Methods. All other chemicals, including the reagents used in the preparation of different buffers and physiological solutions, were of the best quality commercially available.
Data presentation and statistical analysis
In figures, data are expressed as means Ϯ SEM. Statistical comparisons (␣ϭ0.05) were performed by one-way ANOVA followed by the Tukey-Kramer test for multiple comparisons.
The details of the expression of results are specifically described in the references provided in the different Materials and Method sections.
The inhibitory effects of c-RESV and some of the reference drugs are expressed (where appropriate) as IC 50 (concentrations that produce a 50% inhibition), calculated by least-squares linear regression using a fitting program (Origin TM 5.0, Microcal Software, Inc., Northampton, MA) of log molar concentration of the tested compound on percent of maximal pharmacological response obtained with each concentration.
RESULTS
Effects of c-RESV on ROS production by inflammatory rat macrophages
The effects of c-RESV on extra-and intracellular ROS production by thioglycollate-prestimulated rat peritoneal macrophages were investigated using OxyBURST Green probes, and the results are shown in Figure 2 . Extracellular and intracellular ROS production in control inflammatory rat macrophages were, respectively, 81 Ϯ 5 and 35 Ϯ 2 arbitrary fluorescence units per min. c-RESV at concentrations of 1 M or higher significantly inhibited PMA-induced extracellular ROS release, with an IC 50 of 99 Ϯ 8 M (nϭ5; Fig. 2A) . Likewise, c-RESV at concentrations of 1 M or higher significantly inhibited K. lactis-induced intracellular ROS production, with an IC 50 of 14 Ϯ 1.3 M (nϭ5; Fig. 2B ).
O 2 •Ϫ -scavenging capacity of c-RESV
We next investigated the ability of c-RESV to scavenge O 2
•Ϫ generated by an enzymatic system (HX-XO; Fig. 3 ). c-RESV itself was unable to directly reduce NBT. Control activity was 0.04 Ϯ 0.003 A 560 units/min (nϭ5). This value was unaffected by c-RESV (1-100 M), and consequently, it had no effect as a selective scavenger of O 2
•Ϫ (Fig. 3) . SOD (0.1-10 units/ml), however, was capable of removing O 2 •Ϫ generated by the enzymatic HX-XO system (Fig. 3) . The IC 50 value was 0.99 Ϯ 0.08 units/ml (nϭ5).
Effects of c-RESV on XO activity
The effects of c-RESV on XO activity were investigated by measuring its effects on the production of uric acid from xanthine (assays using commercial XO; Fig. 4A ) or on O 2
•Ϫ production from xanthine as quantified by lucigenin-ECL (assays using rat macrophage homogenates as a source of XO; Fig.   Fig. 1 . Generation of c-RESV after the irradiation of t-RESV with UV light (h).
Fig. 2. Effects of c-RESV
(1-100 M) on the extracellular production of ROS induced by PMA (100 ng/ml; A) and on the intracellular production of ROS induced by K. lactis cells/OxyBURST Green H 2 DCF complex (B) in thioglycollate-elicited rat peritoneal macrophages. L(ϩ) ascorbic acid (0.1 mM; A) or sodium azide (1 mM; B) was used as an inhibitory reference drug. Each column represents the mean value Ϯ SEM (indicated by vertical bars) for five experiments. Asterisks indicate significant differences (*, PϽ0.05, and **, PϽ0.01) with respect to control. 4B). c-RESV (1-100 M) did not inhibit XO activity in either assay. By contrast, the reference XO inhibitor allopurinol at 10 M significantly inhibited XO activity in both assays (Fig. 4) .
Effects of c-RESV on NADH/NADPH oxidase activity in inflammatory rat macrophage homogenates
c-RESV itself was unable to reduce lucigenin directly. NADH/ NADPH oxidase activity in control inflammatory rat macrophage homogenates was 5483 Ϯ 411 RLU (nϭ5). c-RESV (10 -100 M) and DPI (1-100 M), a know inhibitor of NADH/NADPH oxidase, decreased NADH/NADPH oxidase activity in a concentration-dependent manner, with IC 50 values of 34 Ϯ 3 and 28 Ϯ 2 M, respectively (nϭ5; Fig. 5 ).
Effects of c-RESV on RNS production by inflammatory rat macrophages stimulated with LPS and IFN-␥ 
Effects of c-RESV on PGE 2 production by inflammatory rat macrophages stimulated with LPS and IFN-␥
We next investigated whether c-RESV inhibits the induction by LPS and IFN-␥ of PGE 2 production in rat peritoneal macrophages. The synthesis of this active product of the COX pathway was inhibited by c-RESV (10 -100 M) and by the nonselective inhibitor of COX expression and COX enzymatic activity indomethacin at 30 M (Fig. 7) . 
Effects of c-RESV on NOS-2 and COX-2 mRNA levels
To determine whether the above effects on NO • and PGE 2 production are related to inhibitory effects in NOS-2 and COX-2 mRNA synthesis, we used a semiquantitative RT-PCR assay applied to RNA extracted from inflammatory rat peritoneal macrophages stimulated with LPS and IFN-␥. Treatment with c-RESV (100 M) significantly reduced levels of NOS-2 and COX-2 mRNA in the macrophage extracts (Fig. 8) .
Effects of c-RESV on synthesis of NOS-2 and COX-2
To determine the effect of c-RESV on NOS-2 and COX-2 protein levels in inflammatory peritoneal macrophages, a slotblot analysis was used. As the corresponding rat antibodies are not commercially available (as far as we know) in these experiments, we used mouse peritoneal macrophages in place of rat macrophages. Treatment of LPS/IFN-␥-stimulated, inflammatory macrophages with c-RESV (10 -100 M) significantly reduced the levels of NOS-2 ( Fig. 9A) and COX-2 (Fig. 9B ).
DISCUSSION
In this study, we have investigated for the first time the effects of c-RESV on inflammatory murine macrophage function. During respiratory burst, macrophages produce and release large amounts of ROS and RNS, which play a role in the destruction of infectious agents; however, current evidence strongly indicates that activated macrophages are also involved in different steps of coronary heart disease (see Introduction) as well as in many inflammatory processes.
K. lactis and PMA rapidly stimulate macrophages to produce ROS [28, 31, 32] through stimulation of NADH/NADPH oxidase and/or XO enzymatic activity (see Introduction). c-RESV (1-10 M) , t-RESV also inhibits ROS production by inflammatory rat peritoneal macrophages [28] .
The above results may be attributable to effects on enzyme activities (XO and/or NADH/NADPH oxidase) or to direct scavenging of O 2
•Ϫ by c-RESV. We therefore first evaluated the O 2 •Ϫ -scavenging capacity of c-RESV, using the enzymatic HX-XO system. O 2 •Ϫ produced in this system reduces NBT to produce the colored compound formazan, which can be quantified spectrophotometrically as a measure of O 2 •Ϫ level [6] ; in this assay system, c-RESV, like t-RESV [6] , did not scavenge O 2 •Ϫ .
In view of these negative results, we investigated the possible effects of c-RESV on XO and/or NADH/NADPH oxidase enzymatic activity.
Like t-RESV (see ref. [6] ), c-RESV did not modify the production of uric acid from xanthine (assays using commercial XO). In addition, c-RESV had no effects on O 2
•Ϫ generation from xanthine, as specifically quantified in the present study by lucigenin-ECL (assays using rat macrophage homogenates as source of XO). These data demonstrate that c-RESV does not affect XO activity. By contrast, c-RESV inhibited NADH/NADPH oxidase enzymatic activity, i.e., the specific chemiluminescence signal emitted by the reaction between lucigenin and O 2
•Ϫ generated from NADPH, in inflammated rat macrophage extracts. These results indicate that the decrease of this enzymatic activity may be responsible, at least in part, for the inhibitory effects of c-RESV on ROS production. Similar effects on NADH/NADPH oxidase have been described previously for t-RESV in rat aortic homogenates [6] . Stimulation of murine macrophages with bacterial wall components (LPS) and IFN-␥ induces them to express large Fig. 7 . Effects of c-RESV (1-100 M) and indomethacin (30 M, a known, nonselective inhibitor of COX expression and COX enzymatic activity) on PGE 2 production by inflammatory rat peritoneal macrophages stimulated with 100 ng/ml LPS and 10 units/ml IFN-␥ for 3 h. Values shown are means Ϯ SEM (nϭ5). *, P Ͻ 0.05, and **, P Ͻ 0.01, with respect to untreated control cells. amounts of NOS-2, which leads to a strong, endogenous NO
• production [33, 34] . This NO • production is abrogated by 10 -100 M c-RESV (present results). Over the same concentration range, t-RESV likewise inhibits the production of nitrogen intermediates by inflammatory rat macrophages stimulated with LPS and IFN-␥ [28] . Activation of murine macrophages with LPS and IFN-␥ induces COX-2 expression and markedly increases PGE 2 production [35] , which is a potent mediator of inflammation and cell proliferation [36] .
In the present study, treatment of LPS/IFN-␥-stimulated inflammatory peritoneal macrophages with c-RESV inhibited PGE 2 production, although only at concentrations of 10 M or more. Similar results have been reported previously for t-RESV in mouse macrophages [37] and murine 3T6 fibroblast [38] , which may explain, at least in part, the inhibition of the 3T6 fibroblast growth produced by this RESV isomer [38] .
To investigate whether the above inhibitory effect of c-RESV on RNS and PGE 2 production may be related (at least in part) to an action on NOS-2/COX-2 gene or protein expression, we also studied the potential effects of c-RESV on NOS-2/COX-2 mRNA and protein levels. Our results show that c-RESV at 100 M inhibits NOS-2 and COX-2 mRNA production (determined by semiquantitative RT-PCR) in inflammatory rat peritoneal macrophages, and c-RESV at 10 -100 M inhibits NOS-2 and COX-2 protein synthesis (determined by slot-blot assay) in inflammatory mouse peritoneal macrophages treated with LPS and IFN-␥. This apparent difference in effective inhibitory concentrations may be a result of the different animal models used (for justification of the choice of mouse macrophages in place of rat macrophages for the determination of NOS-2/COX-2 protein synthesis, see Results). Similar inhibitory effects have been described previously for t-RESV on NOS-2 mRNA levels [39, 40] and on COX-2 enzyme expression [37] in mouse macrophages.
Taking into account that several studies have proposed a positive modulatory role of PGE 2 (see, e.g., ref. [41] ) and ROS [37, 42] on NOS-2 induction in murine macrophages, the inhibitory effects of c-RESV on NOS-2 mRNA and protein levels could be related, at least in part, to the ability of this RESV isomer for decreasing the production of ROS and PGE 2 . Furthermore, as previous studies have shown that NO
• is necessary for maintaining prolonged COX-2 gene expression (see, e.g., ref. [35] ), the action of c-RESV on RNS production observed in the present study could be responsible, at least in part, for the effects of this natural compound on COX-2 mRNA and enzyme levels. Moreover, in the same way as t-RESV in mice [39, 43, 44] or in humans (see, e.g., ref. [45] ), the action of the c-RESV on NOS/COX-2 gene and protein expression described above could be mediated by an inhibition of the nuclear factor-B (NF-B) activation, mainly as a result of the inhibition of the degradation of inhibitor of B␣ (IB␣). The precise effects of c-RESV on the NF-B signaling pathway are currently being evaluated in our laboratory, basically using a DNA hybridization array containing 96 NF-B-related genes. The preliminary results obtained in these experiments (data not shown) indicate that c-RESV produces an increase of the IB gene expression and a down-regulation of two genes of the NF-B family, NF-B1 and NF-B2.
In summary, our data indicate that c-RESV at micromolar concentrations significantly attenuates several components of the macrophage response to proinflammatory stimuli. Specifically, c-RESV blocks O 2
•Ϫ production by inflammatory macrophages (by inhibition of NADPH/NADPH oxidase activity) and inhibits the production of the proinflammatory mediators NO • and PGE 2 (at least in part by inhibition of NOS-2 and COX-2 gene and protein expression). These inhibitory effects on the inflammatory response are qualitatively similar to those previously observed for t-RESV. Therefore, the different spatial conformation of c-RESV (vs. that of the trans isomer, see Fig. 1 ) does not seem to modify markedly its interaction with the potential cellular targets.
As noted in Introduction, because of its effects on macrophage function and on other cell types, t-RESV has been implicated in the protection induced by the prolonged consumption of moderate amounts of wine, especially of red wine, against the incidence of cardiovascular diseases (mainly coronary heart disease). In this context, it has been described previously that the t-RESV concentrations reached in plasma and tissues after the oral administration of this natural compound to rats and humans seem to approach the in vitro active concentrations; an average drinker of wine can, particularly in the long term, absorb a sufficient amount of RESV to explain the beneficial effect of red wine on health (see, e.g., refs. [46, 47] ).
In addition, it is interesting to point out (see also Introduction) that an increased macrophage activation (e.g., through, among others, overproduction of ROS and RNS, abnormally high NADH/NADPH oxidase, NOS-2, and/or COX-2 activities) has been observed in different steps of coronary heart disease and in a number of inflammatory processes (including atherosclerosis). Bearing in mind the above considerations and assuming that c-RESV shows a similar behavior in humans, our results suggest that the beneficial cardioprotective effects of consumption of foods and beverages containing RESV (notably red wine) may thus be a result of the combined effects of the two isomers.
Finally, taking into account the pharmacological properties described for c-RESV in the present study, it can also be concluded that this natural polyphenol may have value as a structural model for the design and subsequent development of new drugs useful for improving the pharmacological treatment of inflammatory diseases involving hyper-responsiveness of phagocytic cells.
